For the Inventor, By the Inventor

Enter assignee name

Olon S.p.a.

USPTO Granted Patents = 26

% Expired Patents = 15.4

CIPO Patents = 4

EPO Patents = 26

Trademarks = 1

Forward Citations = 13

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Giorgio Bertolini (9 out of 12 patents)

Marco Alpegiani (7 out of 41 patents)

Stefano Maiorana (6 out of 28 patents)

4. Mara Sada (6 out of 11 patents)

5. Corrado Colli (5 out of 6 patents)

6. Barbara Novo (5 out of 5 patents)

7. Tania Cristiano (5 out of 5 patents)

8. Filippo Nisic (4 out of 4 patents)

9. Lazzaro Feliciani (4 out of 4 patents)

10. Jacopo Bonanomi (4 out of 4 patents)

11. Aldo Bianchi (4 out of 5 patents)

12. Federica Colombo (4 out of 6 patents)

13. Federico Gassa (3 out of 3 patents)

14. Davide Longoni (3 out of 8 patents)

15. Silvano Ronzoni (2 out of 12 patents)

Core Competencies:

Apalutamide

Lifitegrast

Crisaborole

Pimavanserin

Cangrelor

Enzalutamide

Olaparib

Ospemifene

Tiacumicin B

Levomilnacipran

Tofacitinib

Abiraterone

26 patents: Sort by Forward Citations

1. 11820752 - Process for the preparation of apalutamide (2023-11-21),

2. 11498917 - Process for the preparation of lifitegrast (2022-11-15),

3. 11325922 - Process for the preparation of Crisaborole in a stable crystal form (2022-05-10),

4. 11319288 - Method for the preparation of pimavanserin base (2022-05-03),

5. 11279724 - Efficient method for the preparation of Cangrelor (2022-03-22),

6. 11053227 - Process for preparing intermediates for the synthesis of optically active beta-amino alcohols by enzymatic reduction and novel synthesis intermediates (2021-07-06),

7. 11028082 - Process for the preparation of a novel umeclidinium synthesis intermediate (2021-06-08),

8. 10538479 - Process for the preparation of indanamine derivatives and new synthesis intermediates (2020-01-21),

9. 10329311 - Process for the preparation of crisaborole (2019-06-25),

10. 10059653 - Process for the preparation of indanamine derivatives and new synthesis intermediates (2018-08-28),

11. 10035776 - Process for the preparation of enzalutamide (2018-07-31),

12. 10023535 - Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters (2018-07-17),

13. 9981951 - Crystalline and amorphous forms of Olaparib (2018-05-29),

14. 9975832 - Process for the preparation of ospemifene and fispemifene (2018-05-22),

15. 9970041 - Procedure for the production of tiacumicin B (2018-05-15),

Company Overview

Olon S.p.a. is a prominent player in the pharmaceutical industry, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on providing innovative solutions for various therapeutic areas, leveraging advanced technologies and rigorous quality standards. With a strong commitment to sustainability and regulatory compliance, Olon operates primarily in Europe, contributing to the global healthcare landscape through its expertise in chemical processes and pharmaceutical production.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

26 Patents

#1 in Rodano

#358 in Italy

#24,826 in the World

Olon S.p.a.

Forward Citations = 13

46 inventors:

Giorgio Bertolini (9 out of 12 patents)

Marco Alpegiani (7 out of 41 patents)

Stefano Maiorana (6 out of 28 patents)

4. Mara Sada (6 out of 11 patents)

5. Corrado Colli (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Olon S.p.a.. Retrieved from https://idiyas.com/company/olon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…